 Connection
Aravindhan Veerapandiyan to Male
This is a "connection" page, showing publications Aravindhan Veerapandiyan has written about Male.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.708 |
|
|
|
-
Lewis HS, Srinivasa Sekaran BS, Stefans V, Veerapandiyan A. Clinical Reasoning: A 6-Year-Old Boy With Muscle Twitching. Neurology. 2021 01 12; 96(2):e301-e304.
Score: 0.043
-
Harada Y, Rao VK, Arya K, Kuntz NL, DiDonato CJ, Napchan-Pomerantz G, Agarwal A, Stefans V, Katsuno M, Veerapandiyan A. Combination molecular therapies for type 1 spinal muscular atrophy. Muscle Nerve. 2020 10; 62(4):550-554.
Score: 0.043
-
Ranabothu S, Onteddu S, Nalleballe K, Dandu V, Veerapaneni K, Veerapandiyan A. Spectrum of COVID-19 in children. Acta Paediatr. 2020 09; 109(9):1899-1900.
Score: 0.043
-
Saylam E, Aravindhan A, Stefans V, Veerapandiyan A. Pseudometabolic Presentation of Dystrophinopathy in a Family Due to a Rare Nonsense Mutation. J Clin Neuromuscul Dis. 2020 Jun; 21(4):245-246.
Score: 0.043
-
Harada Y, Zuchner SL, Herrmann DN, Veerapandiyan A. Clinical Reasoning: A case of bilateral foot drop in a 74-year-old man. Neurology. 2020 03 03; 94(9):405-409.
Score: 0.042
-
Guess KE, Harada Y, Hill A, Ferry J, Veerapandiyan A. A Toddler With Bilateral Facial Weakness. Clin Pediatr (Phila). 2020 05; 59(4-5):529-531.
Score: 0.041
-
Veerapandiyan A, Eichinger K, Guntrum D, Kwon J, Baker L, Collins E, Ciafaloni E. Nusinersen for older patients with spinal muscular atrophy: A real-world clinical setting experience. Muscle Nerve. 2020 02; 61(2):222-226.
Score: 0.041
-
Lewis HS, Willis E, Veerapandiyan A. Charcot-Marie-Tooth Disease Type 4J and Multiple Sclerosis. J Clin Neuromuscul Dis. 2019 Dec; 21(2):117-118.
Score: 0.041
-
Veerapandiyan A, Pal R, D'Ambrosio S, Young I, Eichinger K, Collins E, Westesson PL, Kwon J, Ciafaloni E. Cervical puncture to deliver nusinersen in patients with spinal muscular atrophy. Neurology. 2018 08 14; 91(7):e620-e624.
Score: 0.037
-
Veerapandiyan A, Aravindhan A, Takahashi JH, Segal D, Pecor K, Ming X. Use of Head Computed Tomography (CT) in the Pediatric Emergency Department in Evaluation of Children With New-Onset Afebrile Seizure. J Child Neurol. 2018 10; 33(11):708-712.
Score: 0.037
-
Aravindhan A, Shah K, Pak J, Veerapandiyan A. Early-onset epileptic encephalopathy with myoclonic seizures related to 9q33.3-q34.11 deletion involving STXBP1 and SPTAN1 genes. Epileptic Disord. 2018 Jun 01; 20(3):214-218.
Score: 0.037
-
Veerapandiyan A, Abdul-Rahman OA, Adam MP, Lyons MJ, Manning M, Coleman K, Kobrynski L, Taneja D, Schoch K, Zimmerman HH, Shashi V. Chromosome 22q11.2 deletion syndrome in African-American patients: a diagnostic challenge. Am J Med Genet A. 2011 Sep; 155A(9):2186-95.
Score: 0.023
-
Veerapandiyan A, Gallentine WB, Winchester SA, Baker J, Kansagra SM, Mikati MA. Oculogyric crises secondary to lamotrigine overdosage. Epilepsia. 2011 Mar; 52(3):e4-6.
Score: 0.022
-
Veerapandiyan A, Blalock D, Ghosh S, Ip E, Barnes C, Shashi V. The role of cephalometry in assessing velopharyngeal dysfunction in velocardiofacial syndrome. Laryngoscope. 2011 Apr; 121(4):732-7.
Score: 0.022
-
Veerapandiyan A, Winchester SA, Gallentine WB, Smith EC, Kansagra S, Hyland K, Mikati MA. Electroencephalographic and seizure manifestations of pyridoxal 5'-phosphate-dependent epilepsy. Epilepsy Behav. 2011 Mar; 20(3):494-501.
Score: 0.022
-
Veerapandiyan A, Shashi V, Jiang YH, Gallentine WB, Schoch K, Smith EC. Pseudometabolic presentation of dystrophinopathy due to a missense mutation. Muscle Nerve. 2010 Dec; 42(6):975-9.
Score: 0.022
-
Veerapandiyan A, Chinn IK, Schoch K, Maloney KA, Shashi V. Reactive lymphoid hyperplasia in association with 22q11.2 deletion syndrome and a BRCA2 mutation. Eur J Med Genet. 2011 Jan-Feb; 54(1):63-6.
Score: 0.022
-
Baldi O, Kinnett K, Schrader R, Denger B, Truba N, Sorensen S, Veerapandiyan A, Colvin MK. Gaps in the Assessment and Care of Neurodevelopmental and Psychiatric Conditions Associated With Dystrophinopathy. Muscle Nerve. 2025 Mar; 71(3):377-383.
Score: 0.015
-
Kaufman BD, Veerapandiyan A, Soslow JH, Wittlieb-Weber C, Esteso P, Olson AK, Shih R, Bansal N, Lal A, Gambetta K, Hsu D, Cripe L, Villa C, Nandi D. Taking ACTION to detect myocarditis related to recombinant gene transfer therapy for Duchenne Muscular Dystrophy; Consensus recommendations for cardiac surveillance. J Neuromuscul Dis. 2025 Mar; 12(2):173-182.
Score: 0.015
-
Truba N, Sorensen S, Bearden R, Haley B, Spray B, Kinnett K, Schrader R, Veerapandiyan A, Colvin MK. The BELS questionnaire: A novel screening tool for neurodevelopmental and psychiatric symptoms in pediatric dystrophinopathy. Muscle Nerve. 2025 Feb; 71(2):153-158.
Score: 0.015
-
Mendell JR, Muntoni F, McDonald CM, Mercuri EM, Ciafaloni E, Komaki H, Leon-Astudillo C, Nascimento A, Proud C, Schara-Schmidt U, Veerapandiyan A, Zaidman CM, Guridi M, Murphy AP, Reid C, Wandel C, Asher DR, Darton E, Mason S, Potter RA, Singh T, Zhang W, Fontoura P, Elkins JS, Rodino-Klapac LR. AAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trial. Nat Med. 2025 Jan; 31(1):332-341.
Score: 0.014
-
Steele JL, Morrow MM, Sarnat HB, Alkhunaizi E, Brandt T, Chitayat DA, DeFilippo CP, Douglas GV, Dubbs HA, Elloumi HZ, Glassford MR, Hannibal MC, H?ron B, Kim LE, Marco EJ, Mignot C, Monaghan KG, Myers KA, Parikh S, Quinonez SC, Rajabi F, Shankar SP, Shinawi MS, van de Kamp JJP, Veerapandiyan A, Waldman AT, Graf WD. Semaphorin-Plexin Signaling: From Axonal Guidance to a New X-Linked Intellectual Disability Syndrome. Pediatr Neurol. 2022 01; 126:65-73.
Score: 0.012
-
Weerasinghe D, Veerapandiyan A, Stanton M, Herrmann DN, Akmyradov C, Logigian E. Recovery of foot drop in chronic inflammatory demyelinating polyneuropathy (CIDP). Muscle Nerve. 2021 07; 64(1):59-63.
Score: 0.011
-
Feldman AG, Parsons JA, Dutmer CM, Veerapandiyan A, Hafberg E, Maloney N, Mack CL. Subacute Liver Failure Following Gene Replacement Therapy for Spinal Muscular Atrophy Type 1. J Pediatr. 2020 10; 225:252-258.e1.
Score: 0.011
-
Aravindhan A, Veerapandiyan A, Earley C, Thulasi V, Kresge C, Kornitzer J. Child Neurology: Type 1 sialidosis due to a novel mutation in NEU1 gene. Neurology. 2018 03 27; 90(13):622-624.
Score: 0.009
-
Steele SU, Cheah SM, Veerapandiyan A, Gallentine W, Smith EC, Mikati MA. Electroencephalographic and seizure manifestations in two patients with folate receptor autoimmune antibody-mediated primary cerebral folate deficiency. Epilepsy Behav. 2012 Aug; 24(4):507-12.
Score: 0.006
-
Shashi V, Veerapandiyan A, Keshavan MS, Zapadka M, Schoch K, Kwapil TR, Hooper SR, Stanley JA. Altered development of the dorsolateral prefrontal cortex in chromosome 22q11.2 deletion syndrome: an in vivo proton spectroscopy study. Biol Psychiatry. 2012 Oct 15; 72(8):684-91.
Score: 0.006
-
Shah R, Veerapandiyan A, Winchester S, Gallentine W, Mikati MA. Two patients with an anti-N-methyl-D-aspartate receptor antibody syndrome-like presentation and negative results of testing for autoantibodies. Pediatr Neurol. 2011 Dec; 45(6):412-6.
Score: 0.006
-
Holt RL, Provenzale JM, Veerapandiyan A, Moon WJ, De Bellis MD, Leonard S, Gallentine WB, Grant GA, Egger H, Song AW, Mikati MA. Structural connectivity of the frontal lobe in children with drug-resistant partial epilepsy. Epilepsy Behav. 2011 May; 21(1):65-70.
Score: 0.006
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|